Showing results (281-290 of 413) with videos related to

Sort By:
Pageof 42
Pharmacogenomics|October 1, 2015
High-throughput screening identified inherited genetic variations in the EGFR pathway contributing to skin toxicity of EGFR inhibitorsSayed-Mohammad Hasheminasab, Mladen V Tzvetkov, Christian Schumann, et al.
Frontiers in Oncology|February 2, 2023
Local control and patient reported outcomes after online MR guided stereotactic body radiotherapy of liver metastasesLaura Uder, Marcel Nachbar, Sarah Butzer, et al.
Anticancer Research|January 12, 2007
Predictive and prognostic factors in small cell lung carcinoma (SCLC)--analysis from routine clinical practiceWolfgang M Brueckl, Lara Herbst, Annette Lechler, et al.
Communications Biology|November 18, 2021
Transcriptional changes and the role of ONECUT1 in hPSC pancreatic differentiationSandra Heller, Zhijian Li, Qiong Lin, et al.
European Journal of Cancer (Oxford, England : 1990)|January 29, 2016
Dosing to rash?--The role of erlotinib metabolic ratio from patient serum in the search of predictive biomarkers for EGFR inhibitor-mediated skin rashMichael Steffens, Tanusree Paul, Vivien Hichert, et al.
Nature Clinical Practice. Oncology|March 1, 2007
A 25-year-old woman with a gastric GIST and a PET-positive epicardial tumorVolker Kächele, Sandra Pauls, Felix M Mottaghy, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 27, 2020
Technological quality requirements for stereotactic radiotherapy : Expert review group consensus from the DGMP Working Group for Physics and Technology in Stereotactic RadiotherapyDaniela Schmitt, Oliver Blanck, Tobias Gauer, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 26, 2014
Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer: results of the first prospective randomized phase II trialHenriette Golcher, Thomas B Brunner, Helmut Witzigmann, et al.
Pageof 42